0001697751-24-000003.txt : 20240426 0001697751-24-000003.hdr.sgml : 20240426 20240426130732 ACCESSION NUMBER: 0001697751-24-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240426 DATE AS OF CHANGE: 20240426 EFFECTIVENESS DATE: 20240426 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AsclepiX Therapeutics, Inc. CENTRAL INDEX KEY: 0001697751 ORGANIZATION NAME: IRS NUMBER: 832160334 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-511712 FILM NUMBER: 24881162 BUSINESS ADDRESS: STREET 1: 301 WEST 29TH STREET, SUITE 2004 CITY: BALTIMORE STATE: MD ZIP: 21211 BUSINESS PHONE: 610-212-1217 MAIL ADDRESS: STREET 1: 301 WEST 29TH STREET, SUITE 2004 CITY: BALTIMORE STATE: MD ZIP: 21211 FORMER COMPANY: FORMER CONFORMED NAME: AsclepiX Therapeutics, LLC DATE OF NAME CHANGE: 20170209 D 1 primary_doc.xml X0708 D LIVE 0001697751 AsclepiX Therapeutics, Inc. 5237 River Road #334 Bethesda MD MARYLAND 20816 610-212-1217 DELAWARE AsclepiX Therapeutics, LLC Corporation true 2023 Robert Dempsey 5237 River Road #334 Bethesda MD MARYLAND 20816 Executive Officer Steven Altschuler 5237 River Road #334 Bethesda MD MARYLAND 20816 Director Ben Askew 5237 River Road #334 Bethesda MD MARYLAND 20816 Director Josh Barer 5237 River Road #334 Bethesda MD MARYLAND 20816 Director Chris Garabedian 5237 River Road #334 Bethesda MD MARYLAND 20816 Director Jordan Green 5237 River Road #334 Bethesda MD MARYLAND 20816 Director Sapna Srivastava 5237 River Road #334 Bethesda MD MARYLAND 20816 Director Amir Shojaei 5237 River Road #334 Bethesda MD MARYLAND 20816 Executive Officer Niranjan Pandey 5237 River Road #334 Bethesda MD MARYLAND 20816 Executive Officer Jill Tierney 5237 River Road #334 Bethesda MD MARYLAND 20816 Executive Officer Aleksander Popel 5237 River Road #334 Bethesda MD MARYLAND 20816 Executive Officer Biotechnology Decline to Disclose 06b false 2023-07-19 false true false 0 12544498 10044498 2500000 false 9 0 0 0 false AsclepiX Therapeutics, Inc. Robert Dempsey Robert Dempsey Chief Executive Officer 2024-04-26